(Q72998755)
Statements
Rituximab in lymphocyte-predominant Hodgkin disease: results of a phase 2 trial (English)
Steven M Horwitz
Bradley C Ekstrand
Jennifer B Lucas
Zhen Fan
Sheila Breslin
Yasodha Natkunam
Sandra J Horning
13 February 2003